期刊文献+

奥氮平与利培酮对慢性精神分裂症认知功能的疗效 被引量:8

Curative effects of olanzapine and risperidone on the cognitive function of patients with chronic schizophrenia
下载PDF
导出
摘要 目的探讨奥氮平与利培酮在治疗慢性精神分裂症的认知功能的临床效果。方法选择本院2010—2012年收治的精神分裂患者98例,按随机数字法分为2组,分别给予奥氮平及利培酮治疗,分别在入组、治疗12周及6个月进行PAN-SS量表评定以及认知功能的测定。结果 A组42例和B组44例完成了6个月的治疗,所有患者从基线到6个月精神症状均显著改善,6个月时认知功能显著提高。结论奥氮平和利培酮均能显著改善慢性精神分裂患者的认知功能。 Objective To investigate the clinical effect of olanzapine and risperidone on the cognitive function of patients with chronic schizophrenic.Methods 98 patients with chronic schizophrenic in our hospital from 2010 to 2012 were randomly divided into A group(treated by olanzapine)and B group(treated by risperidone).The curative effects of two group were assessed by PANSS rating scale as well as the determination of cognitive function after 12 weeks and 6 months of treatment.Results 42 cases in group A and 44 patients in group B had finished 6 months of treatment which could significantly improve the mental symptom and cognitive function.Conclusion Risperidone and olanzapine can improve the cognitive function and clinical effect.
作者 徐承裕
出处 《中国实用神经疾病杂志》 2013年第16期1-3,共3页 Chinese Journal of Practical Nervous Diseases
关键词 慢性精神分裂症 奥氮平 利培酮 认知功能 Chronic schizophrenia Olanzapine Risperidone Cognitive function
  • 相关文献

参考文献11

二级参考文献70

  • 1牛雅娟,黄文升,郝学儒,杨甫德,吉中孚.氯氮平和利培酮治疗精神分裂症患者比较研究[J].上海精神医学,2003,15(5):276-278. 被引量:10
  • 2Stipe E, Remington GI, Dursun SM, et al. A canadian multicenter trial assessing memmory and executive functions in patients with schizophrenia spectrum disorders treated with olanzapine [J ]. J cline Psychopharmacol, 2003,23 (4) : 400
  • 3Lieberman JA, Mailman RB, et al. Serotonergic basis of antipsychotic drug effects in schizophrenia[J]. Biol Psychiatry, 1999,44 : 1099
  • 4Galletly CA,clark CR,Macfarlane AC. Treatment congnitive dysfunction in patients with schizophrenia [J]. J Psychiatry-Neuroscience, 2000,25 : 117
  • 5Addington J, Addington DE, Hutchinson JE. Neurocognition in early psychosis:a 2 - year follow-up [J]. Schizophr Res, 2001,49(1-2) : 128
  • 6Woodward ND,Purdon SE,Meltzer HY,et al.A meta-analysis of neuropsychological change to clozapine,olanzapine,quetiapine,and risperidone in schizophrenia.Int J Neuropsychopharmacol,2005,8(3):457-472.
  • 7Riedel M,Schennech-Wolff R,Musil R,et al.Neurocognition and its influencing factors in the treatment of schizophrenia-effects of aripiprazole,olanzapine,quetiapine and risperidone.Hum Psychopharmacol,2010,25(2):116-125.
  • 8Krausz M,Moritz S,Lambert M,et al.Dosage of conventional neuroleptic medication and subjective cognitive functioning in schizophrenia.Int Clin Psychopharnlacol,2000,15(2):77-81.
  • 9中华医学会精神科分会.中周精神障碍分类与诊断标准(CCMD-Ⅲ).济南:山东科学技术出版社,2001:75-78.
  • 10张明同.精神科评定量表手册.长沙:湖南科学技术出版社,1993:162-165.

共引文献56

同被引文献68

引证文献8

二级引证文献114

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部